Header Logo

Connection

JOHN VIERLING to Immunosuppressive Agents

Back to Details
This is a "connection" page, showing publications JOHN VIERLING has written about Immunosuppressive Agents.
JOHN VIERLING
Connection Strength
1.374
Immunosuppressive Agents
  1. Immunosuppressive Treatment Regimens in Autoimmune Hepatitis: Systematic Reviews and Meta-Analyses Supporting American Association for the Study of Liver Diseases Guidelines. Hepatology. 2020 08; 72(2):753-769.
    View in: PubMed
    Score: 0.492
  2. Evolving new therapies of autoimmune hepatitis. Clin Liver Dis. 2002 Aug; 6(3):825-50, ix.
    View in: PubMed
    Score: 0.141
  3. Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy. JCO Clin Cancer Inform. 2019 03; 3:1-12.
    View in: PubMed
    Score: 0.111
  4. Expert clinical management of autoimmune hepatitis in the real world. Aliment Pharmacol Ther. 2017 03; 45(5):723-732.
    View in: PubMed
    Score: 0.096
  5. Cutting edge issues in autoimmune hepatitis. J Autoimmun. 2016 Dec; 75:6-19.
    View in: PubMed
    Score: 0.093
  6. Autoimmune hepatitis. Front Med. 2015 Jun; 9(2):187-219.
    View in: PubMed
    Score: 0.085
  7. Diagnosis and treatment of autoimmune hepatitis. Curr Gastroenterol Rep. 2012 Feb; 14(1):25-36.
    View in: PubMed
    Score: 0.068
  8. Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent. Aliment Pharmacol Ther. 2004 May 01; 19(9):1033-9.
    View in: PubMed
    Score: 0.040
  9. Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy. Drug Saf. 2024 Apr; 47(4):321-332.
    View in: PubMed
    Score: 0.039
  10. The clinical and immunologic impact of using interferon and ribavirin in the immunosuppressed host. Liver Transpl. 2003 Nov; 9(11):S79-89.
    View in: PubMed
    Score: 0.039
  11. Practical Consideration for Drug Monitoring of Tacrolimus in Liver Transplantation Recipients with SARS-CoV-2 Infection. Liver Transpl. 2022 01; 28(1):127-130.
    View in: PubMed
    Score: 0.033
  12. Therapeutic trials of biologics in primary biliary cholangitis: An open label study of abatacept and review of the literature. J Autoimmun. 2019 07; 101:26-34.
    View in: PubMed
    Score: 0.028
  13. Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis. Am J Gastroenterol. 1999 Jan; 94(1):241-8.
    View in: PubMed
    Score: 0.028
  14. Autoimmune hepatitis. Nat Rev Dis Primers. 2018 04 12; 4:18017.
    View in: PubMed
    Score: 0.026
  15. Unmet needs and new models for future trials in autoimmune hepatitis. Lancet Gastroenterol Hepatol. 2018 05; 3(5):363-370.
    View in: PubMed
    Score: 0.026
  16. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation. Transplant Proc. 1996 Apr; 28(2):1011-3.
    View in: PubMed
    Score: 0.023
  17. Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation. Liver Transpl Surg. 1997 Jul; 3(4):398-406.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.